LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Big Pharma Research Racket Is Killing People
Jun-23-06 Over the past six years, ten FDA approved drugs have been withdrawn from the market due to deaths and injuries, leading lawmakers to accuse the FDA of not doing its job in protecting the public from unsafe drugs and to call for measures of improvement. On June 20, 2006, the New York Times reported that "two influential senators are expected within weeks t... - Drug Companies Still Peddling Risperdal and Zyprexa For Off-Label Use
Jun-17-06 According to Kelly O'Meara, author of the newly released book, Psyched Out, America has a drug problem. "It's not as covert as those illicit and illegal "Just Say No" drugs," she says, "but, rather, Americans have become drug users by way of being diagnosed as suffering from one or a number of alleged mental disorders." "Sharing one's feelings with a doc... - Lawmakers Demand Answers about Ketek from FDA
Jun-14-06 The FDA has continued to cite a fraudulent study in information released to the public about the safety of the antibiotic Ketek. On January 20, 2006, the agency issued a Public Health Announcement, in response to an article in the Annals of Internal Medicine, where researchers reported three cases of severe liver problems in patients taking Ketek. The ar... - Congressmen on War Path over FDA approval of Ketek
Jun-12-06 French drug giant Sanofi-Aventis has stopped enrolling pediatric patients in clinical trials for Ketek. On June 9, 2006, the drug maker said it halted tests on its own to ensure that trials of the drug complied with FDA requirements. The company denied that the studies were suspended because of safety concerns. However, the move jives with the recently in... - Nursing Home Industry - Breeding Ground for Whistleblowers
Jun-2-06 One of the most effective weapons the government has for unearthing fraud against Medicare and Medicaid in the nursing home industry is the False Claims Act. The fraud is so rampant in that industry that it should be officially designated as a breeding ground for whistleblowers. A provision in the FCA, called Qui Tam, allows persons with evidence of fraud... - Beverly Enterprises - Poster Child Of Fraud And Neglect In Nursing Home Industry
Jun-1-06 Nowhere in the nursing home industry is the corruption, patient neglect and abuse and Medicare and Medicaid fraud more blatant than within the giant nursing home chain of Beverly Enterprises. Based in Fort Smith, it reportedly operates more than 400 nursing facilities, assisted living centers and hospices in 23 states and the District of Columbia. The cha... - Pfizer and GlaxoSmithKline Help Send Kids To Prison
May-29-06 In 2003, the pharmaceutical industry passed out $16.4 billion worth of free drug samples to doctors. These so-called free samples are literally killing people. Two young lads who were lucky enough to get free samples of Zoloft are now sitting in prison. After visits to their family doctors, Christopher Pittman and Zachary Schmidkunz were both sent home wi... - Neurontin Deal - Slap On The Hand To Pfizer
May-25-06 The off-label prescribing of drugs has become a serious problem over the past decade. Doctors are adjusting dosage levels and prescribing drugs for medical indications and treatment durations for which the drugs were never approved or intended. When the FDA approves a drug, it also approves the labeling for the drug, which explains the manner in which the... - FDA Used to Shield Big Pharma From Lawsuits
May-12-06 In January 2006, the FDA announced the Bush administration's latest gift to Big Pharma in a statement that said people who believe they have been injured by drugs approved by the FDA should not be allowed to sue drug companies in state courts. "We think that if your company complies with the FDA processes, if you bring forward the benefits and risks of yo... - Whistleblower Mark Livingston Battles Wyeth Pharmaceuticals
May-10-06 Washington DC Attorney, Jason Zuckerman, says a positive result of the recent corporate scandals is the recognition of the value of whistleblowers in exposing fraud, corruption, and other wrongdoing within a company. As a result of a shift in the public's perception, he says, some whistleblowers are viewed as heroes for taking on powerful corporations lik... - Ex-Pfizer VP Peter Rost Takes On Goliath
May-9-06 Beginning in 1997, Pharmacia, currently a subsidiary of Pfizer, sought to boost its sales of the drug Genotropin. To that end, the company illegally marketed the drug to spur growth in short children and as an anti-aging drug for adults looking for the fountain of youth. In a nutshell, the off-label marketing scheme included: (1) direct payments to doct... - Kids Dying From Off-Label Use Of Antipsychotics
May-5-06 A recent USA Today sponsored review of the FDA database from 2000 to 2004 found at least 45 deaths in children under 18 with atypical antipsychotics listed as the "primary suspect," and 1,328 reports of other serious side effects, some life-threatening. Atypical antipsychotics are a relatively new class of drugs approved by the FDA for the treatment of a... - Tequin's Serious Injuries - Bristol-Myers Feigns Ignorance
May-1-06 On April 27, 2006, Dow Jones reported that Bristol-Myers Squibb had decided to stop selling Tequin, an antibiotic found to increase the risk of blood-sugar problems. BMS made a "recent decision to stop all our commercialization efforts" for Tequin and to return the rights to Kyorin, Dow quoted Chief Financial Officer, Andrew Bonfield, as saying. BMS licen... - Our Home an Asbestos Hazard Site
Apr-26-06 Angelica Frances and her family moved to Sedalia, Missouri and bought a home. Little did they know that soon after moving in, they would be forced to leave. The entire house was contaminated with asbestos. "We arrived in Missouri from California in October, 2005. We were moving here for work and family reasons and bought the property from a real estate/... - Drip Drip Drip - Paxil Info Leaks Out
Apr-25-06 Secrecy agreements in litigation hide information about defective products or a company's negligence, and sometimes go so far as to prohibit the parties from discussing that there ever was a lawsuit. Such is the case with Paxil and as a result, unwitting patients continued to take the drug long after its dangers were known to GlaxoSmithKline. Many lawsuit... - ReNu contact lens solution spells Agony
Apr-21-06 I soaked my contact lenses overnight in Bausch & Lomb's ReNu with MoistureLoc Multi-Purpose Solution. The next morning when I put my contacts back in, my eyes started to burn and they got a whole lot worse. The pain was like someone was stabbing me repeatedly in my eyes with needles. That was June, 2005 and I'm still suffering. Susan Parks (not her real... - Is Shelf Life Of Zicam Nasal Spray In Jeopardy?
Apr-17-06 On January 20, 2006, Matrixx Initiatives, Inc, the maker of Zicam cold remedy products , agreed to settle a class action lawsuit by paying out $12 million to 340 plaintiffs, who claim Zicam nasal spray permanently damaged their sense of smell, a condition known as anosmia. In the summer of 2005, Matrixx also settled the only lawsuit that has gone to trial,... - Accutane - Another Case of Too Little Too Late
Apr-12-06 Accutane is prescribed to treat a type of severe acne called nodular acne which causes red, swollen, tender lumps to form under the skin. Accutane is supposed to be used only when all other treatments, including antibiotics, have failed. The treatment usually lasts 4 or 5 months, at a cost of about $3000, including lab tests and doctor's visits. The drug... - Home Depot on Bottom Rung of the Human Relations Ladder
Apr-6-06 Jane Govenor gave Home Depot 15 years of her life: long, honest and loyal hours. As assistant manager, she averaged 70 hours per week. "I think it's sad because Home Depot used to be a great company. Someone thanked me at one time, but I would have preferred a bonus," she says. (Last year, Home Depot CEO Bob Nardelli received $27 million-plus, including seve... - Gambro Healthcare - Dialysis Fraud Pays Big Bucks
Mar-29-06 Medicare payments for dialysis cost the US government $5 billion a year. The global market for chronic dialysis services is worth approximately $43 billion and the US market is the largest in the world in terms of value. Worldwide, by the end of 2005, the number of dialysis patients reached 1.5 million. Of that number, approximately 23% patients were trea...